Longeveron Inc. Common Stock (LGVN) is a publicly traded Healthcare sector company. As of July 13, 2026, LGVN trades at $0.67 with a market cap of $21.33M and a P/E ratio of -0.26. LGVN moved +0.00% today. Year to date, LGVN is +34.17%; over the trailing twelve months it is -55.00%. Its 52-week range spans $0.48 to $2.24. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces LGVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LGVN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.67 |
| Market Cap | $21.33M |
| P/E Ratio | -0.26 |
| EPS | $-2.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.24 |
| 52-Week Low | $0.48 |
| Volume | 262.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.39M |
| Net Income | $-15.97M |
| Gross Margin | 78.76% |
3 analysts cover LGVN: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.